Introduction: Cardiovascular health and disease prevention in clinical practice

Br J Cardiol 2013;20(suppl 3):S1–S19 Leave a comment
Click any image to enlarge
Sponsorship Statement: MSD provided financial support for this publication. The supplement was conceived by the authors. Content and articles were fully developed and written by the authors except the DYSIS article, which was written in collaboration with MSD. Full editorial control of the supplement rested with the authors. The ASPIRE-2-PREVENT study and the Croi MyAction programme, Ireland, were partly funded though unrestricted educational grants by MSD UK and MSD Ireland, respectively. DYSIS was an MSD sponsored study. The supplement was reviewed by MSD for ABPI compliance only.

Insights from the world of cardiology

Promoting cardiovascular health is central to the national strategy to reduce premature mortality in our population. In this supplement, we offer a new approach to cardiovascular disease (CVD) prevention through the MyAction preventive cardiology programme, developed by Imperial College London. This nurse-led, multi-disciplinary, family-centred service embraces all patients with atherosclerotic disease – coronary heart disease, stroke and peripheral arterial disease – together with those identified through Health Checks to be at high risk of developing CVD in one community-based programme. In this supplement, we describe the studies that compiled the rationale for MyAction, our experience in delivering this programme in different communities and our approach to education and training through our Imperial College Masters degree programme in preventive cardiology: cardiovascular health and disease prevention. All health professionals are welcome to visit MyAction and join us in our ambitions to achieve excellence in preventive care for all our patients.

The ASPIRE-2-PREVENT study was partly funded through an unrestricted educational grant by MSD and the DYSIS study was sponsored by MSD. These studies were conducted together and we thank all the participants, local clinical staff and the scientific committee members.

Disclaimer: Medinews Cardiology Limited advises healthcare professionals to consult up-to-date Prescribing Information and the full Summary of Product Characteristics available from the manufacturers before prescribing any product. Medinews Cardiology Limited cannot accept responsibility for any errors in prescribing which may occur.